90 - Meeting the Full Potential of DAA Therapies for HCV

10/3/2019

3:15 PM - 4:30 PM

Room: Walter E. Washington Convention Center, 207 AB

MOC Credit: Maximum of 1.25 hours of MOC Credit
CME Credit: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
ACPE Credit: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: 0221-9999-19-348-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

discuss novel approaches to use of HCV positive donor organs in the DAA era
discuss emerging data of treatment of HCV in pregnancy and safety of DAA in pregnant women
discuss treatment approaches to acute HCV infection in MSM

Presentations:

3:15 PM - 3:40 PM
870 - HCV positive donor to negative recipient organ transplant: Is There Anything we can’t do?
Raymond Chung, MD – Massachusetts General Hospital
3:40 PM - 4:05 PM
871 - Test and Treat in Pregnancy: Are we There Yet?
Catherine Chappell, MD, MSc – University of Pittsburgh
4:05 PM - 4:30 PM
872 - HCV Treatment as Prevention in MSM: Challenges and Opportunities
Anne Boerekamps, MD – Erasmus Medical Center

Moderator(s)

Susanna Naggie, MD

Associate Professor
Duke University
Durham, North Carolina

Disclosure: Abbvie: Grant/Research Support
BioMarin: Consultant
FHI360: Consultant
Gilead Sciences: Grant/Research Support
PRA: Consultant
Tacere: Grant/Research Support
Vir Biotechnology: Consultant
David Wyles, MD

Chief Division of Infectious Diseases
Denver Health
Denver, CO

Disclosure: Gilead Sciences: Grant/Research Support

Speaker(s)

Anne Boerekamps, MD

Resident internal medicine
Erasmus Medical Center
Rotterdam, Netherlands

Disclosure: Nothing to disclose
CC

Catherine Chappell, MD, MSc

Assistant Professor
University of Pittsburgh
Pittsburgh, PA

Disclosure: Gilead Sciences: Advisory Board, Research Grant
Merck: Research Grant
RC

Raymond Chung, MD

Director of Hepatology and Liver Center
Massachusetts General Hospital
Boston, MA

Disclosure: Abbvie: Grant/Research Support
Boeringher-Ingelheim: Grant/Research Support
bristol myers squibb: Grant/Research Support
Gilead Sciences: Grant/Research Support
Janssen: Grant/Research Support
Merck: Grant/Research Support